Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Quantin

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Revue De Pneumologie Clinique|November 13, 2004
[Do combinations without cisplatin represent an alternative to conventional chemotherapy in non-small cell lung cancers?]J-L Pujol, W Jacot, J-L Breton, et al.
Revue Des Maladies Respiratoires|November 7, 1998
[Neuron-specific enolase (NSE) in the surveillance of small cell cancers. An evaluation of the prognostic information using Markov's model]J L Pujol, J M Boher, J Grenier, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 1996
Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPSJ L Pujol, J Grenier, E Parrat, et al.
Chest|January 30, 1999
Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancerJ L Pujol, T Lafontaine, X Quantin, et al.
Revue Des Maladies Respiratoires|March 29, 2005
[Evidence based pneumology: 3rd update workshop to the SPLF. Smoking: from prevention to weaning]N Wirth, A Bohadana, A Spinosa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancerX Quantin, J L Pujol, A Paris, et al.
Human Reproduction Update|August 6, 2010
Effects of cigarette smoking on reproductionC Dechanet, T Anahory, J C Mathieu Daude, et al.
American Journal of Clinical Oncology|April 25, 2000
Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated doseX Quantin, A Rivière, J P Daurès, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancerP Rebattu, X Quantin, C Ardiet, et al.
Revue Des Maladies Respiratoires|November 28, 2006
[Mediteranean environment and thoracic pathology]P Godard, R Chiron, J-L Pujol, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Revue De Pneumologie Clinique|November 13, 2004
[Do combinations without cisplatin represent an alternative to conventional chemotherapy in non-small cell lung cancers?]J-L Pujol, W Jacot, J-L Breton, et al.
Revue Des Maladies Respiratoires|November 7, 1998
[Neuron-specific enolase (NSE) in the surveillance of small cell cancers. An evaluation of the prognostic information using Markov's model]J L Pujol, J M Boher, J Grenier, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 1996
Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPSJ L Pujol, J Grenier, E Parrat, et al.
Chest|January 30, 1999
Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancerJ L Pujol, T Lafontaine, X Quantin, et al.
Revue Des Maladies Respiratoires|March 29, 2005
[Evidence based pneumology: 3rd update workshop to the SPLF. Smoking: from prevention to weaning]N Wirth, A Bohadana, A Spinosa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancerX Quantin, J L Pujol, A Paris, et al.
Human Reproduction Update|August 6, 2010
Effects of cigarette smoking on reproductionC Dechanet, T Anahory, J C Mathieu Daude, et al.
American Journal of Clinical Oncology|April 25, 2000
Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated doseX Quantin, A Rivière, J P Daurès, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancerP Rebattu, X Quantin, C Ardiet, et al.
Revue Des Maladies Respiratoires|November 28, 2006
[Mediteranean environment and thoracic pathology]P Godard, R Chiron, J-L Pujol, et al.
Pageof 5